These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20831355)

  • 1. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
    Chihara S; Shimizu R; Furukata S; Hoshino K
    Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
    Aradhyula S; Manian FA; Hafidh SA; Bhutto SS; Alpert MA
    South Med J; 2006 May; 99(5):518-20. PubMed ID: 16711316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
    Rao S; Kupfer Y; Pagala M; Chapnick E; Tessler S
    Scand J Infect Dis; 2011 May; 43(5):386-8. PubMed ID: 21198337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.
    Pogue JM; DePestel DD; Kaul DR; Khaled Y; Frame DG
    Transpl Infect Dis; 2009 Oct; 11(5):467-70. PubMed ID: 19638004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracolonic Vancomycin Through Laprascopic Appendicostomy for Treatment of Severe Clostridium difficile Colitis Does Not Get Systemic Absorption.
    Alhazmi L; Almeshal N; Assaly R
    Am J Ther; 2017; 24(5):e616. PubMed ID: 28301334
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clostridium difficile associated diarrhea: reliable therapy with vancomycin capsules].
    MMW Fortschr Med; 2012 Sep; 154(16):64-5. PubMed ID: 23045940
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
    Tedesco FJ; Gordon D; Fortson WC
    Am J Gastroenterol; 1985 Nov; 80(11):867-8. PubMed ID: 4050760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomembranous colitis due to Clostridium difficile.
    Kiliçarslan R; Toprak H; Ozturk F; Kocakoç E
    JBR-BTR; 2014; 97(3):158-9. PubMed ID: 25223126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
    Kerst JM; van der Lelie J; Kuijper EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1137-40. PubMed ID: 11433658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous endoscopic colostomy for treatment of an antibiotic-induced pseudomembranous colitis].
    Prassler R
    Dtsch Med Wochenschr; 2008 Oct; 133(44):2268-71. PubMed ID: 18946851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Length of vancomycin administration for treatment of clostridium difficile-associated diarrhea may depend on presentation of colonic ulcer.
    Yamashita M; Nomura K; Fujimoto Y; Morimoto Y; Ohshiro M; Tsutsumi Y; Kobayashi T; Kaneko H; Yasuhawa S; Yanagisawa A; Toshikazu Y; Masafumi T;
    Hepatogastroenterology; 2009; 56(90):313-6. PubMed ID: 19579589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG
    Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract]   [Full Text] [Related]  

  • 20. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Bartlett JG; Tedesco FJ; Shull S; Lowe B; Chang T
    Gastroenterology; 1980 Mar; 78(3):431-4. PubMed ID: 7053190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.